• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Nanoparticles

Nanoparticles deliver engineered protein to prevent joint damage

October 7, 2016 By Sarah Faulkner

Injected nanoparticles inhibit inflammation

Researchers at Washington University have developed nanoparticles to treat the inflammation that wears away at joint cartilage in patients with osteoarthritis. Traditional treatment methods to reduce inflammation involve steroid injections, but the body quickly washes them away, leaving the cells vulnerable to more inflammation. “I see a lot of patients with osteoarthritis, and there’s really […]

Filed Under: Nanoparticles, Orthopedics, Research & Development Tagged With: Washington University

‘Connectosomes’ efficiently deliver chemo to targeted cells

October 5, 2016 By Sarah Faulkner

Researchers have developed a new form of nanoparticles called “connectosomes” that can efficiently deliver chemotherapy to human cells more efficiently than traditional delivery methods, according to a report out of the University of Texas at Austin. The team, who published their research in the Journal of the American Chemical Society, equipped the connectosomes with gap junctions […]

Filed Under: Featured, Nanoparticles, Oncology, Research & Development Tagged With: University of Texas at Austin

Hospital researchers explore MRI for drug delivery

October 3, 2016 By Sarah Faulkner

Boston Children's Hospital

Researchers have programmed an MRI scanner to simultaneously monitor magnetized particles while propelling them through blood vessels as a means to locally deliver drugs. Existing approaches combine the magnetic force from an MRI scanner with the force produced by particle collisions. But traditionally, it’s challenging to image using the MRI scanner and propel the particles […]

Filed Under: Imaging, Nanoparticles, Research & Development Tagged With: Boston Children's Hospital

Dicerna bails on EnCore lipid nanoparticle tumor delivery program

September 27, 2016 By Sarah Faulkner

Dicerna raises $70m, reels in losses for Q4

Dicerna Pharmaceuticals (NSDQ:DRNA) said yesterday that it plans to spike the development program for its lipid nanoparticle delivery system for solid tumors because its preliminary results don’t meet expectations. The Cambridge, Mass.-based company evaluated its lipid nanoparticle, DCR-MYC, in a pair of clinical trials – a Phase I study of patients with solid tumors, hematological […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Nanoparticles, Oncology Tagged With: Dicerna Pharmaceuticals

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 8
  • Page 9
  • Page 10

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS